Success Metrics

Clinical Success Rate
62.5%

Based on 5 completed trials

Completion Rate
63%(5/8)
Active Trials
0(0%)
Results Posted
80%(4 trials)
Terminated
3(33%)

Phase Distribution

Ph phase_4
2
22%
Ph phase_3
2
22%
Ph not_applicable
4
44%

Phase Distribution

0

Early Stage

0

Mid Stage

4

Late Stage

Phase Distribution8 total trials
Phase 3Large-scale testing
2(25.0%)
Phase 4Post-market surveillance
2(25.0%)
N/ANon-phased studies
4(50.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

62.5%

5 of 8 finished

Non-Completion Rate

37.5%

3 ended early

Currently Active

0

trials recruiting

Total Trials

9

all time

Status Distribution
Active(1)
Completed(5)
Terminated(3)

Detailed Status

Completed5
Terminated3
Enrolling by invitation1

Development Timeline

Analytics

Development Status

Total Trials
9
Active
0
Success Rate
62.5%
Most Advanced
Phase 4

Trials by Phase

Phase 32 (25.0%)
Phase 42 (25.0%)
N/A4 (50.0%)

Trials by Status

completed556%
enrolling_by_invitation111%
terminated333%

Recent Activity

Clinical Trials (9)

Drug Details

Intervention Type
DRUG
Total Trials
9